Axbio logo — Pioneering the future of gene sequencing and diagnostics thr...

Axbio

Pioneering the future of gene sequencing and diagnostics through innovative, high-performance equipment and comprehensive industrial solutions

Founded 2016 Series B Total: $110.00M Manufacturing, Medical Devices

General Information

Company Name Axbio
Founded Year 2016
Industries Manufacturing, Medical Devices
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Axbio. To contact Axbio, visit axbio.cn.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Axbio compare?

A PDF of Axbio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Axbio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Axbio

Axbio is a pioneering company in the field of gene sequencing and diagnostics. Established in 2016, the company focuses on manufacturing next-generation high-end equipment for gene sequencing and diagnostics, along with providing comprehensive industrial solutions. Axbio's commitment to innovation and high performance is reflected in its slogan, which encapsulates its mission. Recently, the company received a significant Series B investment of $100.00M on 20 June 2022. The investment was led by Cambridge Capital, CBC Group, Wuyuan Capital, AstraZeneca Pharmaceutical, YF Capital, and CMG-SDIC Capital Management. Axbio operates within the Manufacturing and Medical Devices industries, positioning itself at the forefront of technological and industrial advancement.

Taxonomy: gene sequencing, diagnostics, high-performance equipment, industrial solutions, next-generation technology

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $100.00M 6
Cambridge Capital, CBC Group +4
20 Jun 2022
Series B $10.00M 4
Kaitai Capital, 5Y Capital +2
31 Oct 2021
Convertible Note Undisclosed -
08 Aug 2016

Axbio Alternatives & Competitors

View All Alternatives
Axbio vs

ME Instruments Inc. is a technology company specializing in the research, development, transformatio...

Series B
1 employees
Manufacturing, Medical Devices
Axbio vs
Kumovis
Kumovis Germany

Kumovis offers medical manufacturing solutions with 3D printing, clean room tech, and regulatory sup...

Acquired
8 employees
Health Care, Manufacturing
Axbio vs

Biotechnology | IVD | Medical Device

281 employees
Biotechnology, Design

FAQ About Axbio

Pioneering the future of gene sequencing and diagnostics through innovative, high-performance equipment and comprehensive industrial solutions
Axbio was founded in 2016.
Axbio operates in Manufacturing and Medical Devices. Its work centres on gene sequencing, diagnostics, high-performance equipment and industrial solutions.
Axbio has completed 3 funding rounds, raising a total of $110.00M. The latest funding stage is Series B.
Top alternatives and competitors to Axbio include ME Instruments Inc., Kumovis, J Mitra & Co Pvt Ltd, Peerless Biotech Pvt. Ltd. Official, Multiwave Technologies AG. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Axbio and ME Instruments Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Axbio, https://bouncewatch.com/company/axbio, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes